CYP2C19 and ischemic stroke: We, therefore, estimate the PAF for ischaemic stroke—the proportion of ischaemic strokes in this population that would not have occurred if clopidogrel efficacy was not affected by CYP2C19 LoF variants—to be 12.9% (95% CI 1.4% to 20.8%).